Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

VERX
Vanguard FTSE Developed Europe ex UK ETF
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $360.943 $92.68 $89.151 $81.122
Short term investments $8.65 $9.101 $9.545 $8.326
Net receivables $120.082 $133.149 $141.752 $129.018
Inventory
Total current assets $514.809 $266.836 $266.621 $238.103
Long term investments
Property, plant & equipment $121.467 $114.367 $115.339 $115.603
Goodwill & intangible assets $290.023 $294.213 $299.009 $293.332
Total noncurrent assets $509.021 $488.966 $493.306 $481.965
Total investments $8.65 $9.101 $9.545 $8.326
Total assets $1,023.83 $755.802 $759.927 $720.068
Current liabilities
Accounts payable $24.22 $22.431 $23.596 $24.379
Deferred revenue $299.741 $300.991 $292.72 $266.815
Short long term debt $3.889 $6.193 $6.291 $6.782
Total current liabilities $439.069 $442.504 $440.779 $433.106
Long term debt $348.525 $59.022 $60.677 $62.373
Total noncurrent liabilities $351.631 $63.168 $66.167 $66.79
Total debt $352.414 $65.215 $66.968 $69.155
Total liabilities $790.7 $505.672 $506.946 $499.896
Stockholders' equity
Retained earnings $7.262 $2.098 -$0.586 -$15.92
Other stockholder equity -$29.086 -$25.77 -$21.742 -$29.312
Total stockholder equity $233.13 $250.13 $252.981 $220.172
(in millions USD) 2023 2022 2021
Current assets
Cash $89.151 $106.748 $98.206
Short term investments $9.545 $11.173
Net receivables $141.752 $102.885 $76.929
Inventory
Total current assets $266.621 $241.189 $195.671
Long term investments
Property, plant & equipment $115.339 $132.955 $118.639
Goodwill & intangible assets $299.009 $296.035 $306.144
Total noncurrent assets $493.306 $478.003 $474.536
Total investments $9.545 $11.173
Total assets $759.927 $719.192 $670.207
Current liabilities
Accounts payable $23.596 $14.329 $13
Deferred revenue $292.72 $279.136 $249.01
Short long term debt $6.291 $6.377 $4.217
Total current liabilities $440.779 $403.209 $369.132
Long term debt $60.677 $67.14 $24.388
Total noncurrent liabilities $66.167 $86.258 $70.991
Total debt $66.968 $73.517 $28.605
Total liabilities $506.946 $489.467 $440.123
Stockholders' equity
Retained earnings -$0.586 $12.507 $24.811
Other stockholder equity -$21.742 -$27.752 -$17.497
Total stockholder equity $252.981 $229.725 $230.084

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $161.104 $156.781 $154.914 $145.027
Cost of revenue $58.416 $60.989 $61.311 $56.871
Gross profit $102.688 $95.792 $93.603 $88.156
Operating activities
Research & development $14.614 $16.845 $12.898 $16.772
Selling, general & administrative $76.415 $76.033 $73.906 $69.304
Total operating expenses $95.143 $97.357 $96.094 $90.174
Operating income $7.545 -$1.565 -$2.491 -$2.018
Income from continuing operations
EBIT $7.545 -$1.565 -$2.491 -$2.018
Income tax expense $2.2 -$4.535 -$21.847 $0.784
Interest expense $0.181 $0.286 $4.022 $0.597
Net income
Net income $5.164 $2.684 $15.334 -$3.399
Income (for common shares) $5.164 $2.684 $15.334 -$3.399
(in millions USD) 2023 2022 2021
Revenue
Total revenue $572.387 $491.624 $425.548
Cost of revenue $223.808 $193.132 $161.892
Gross profit $348.579 $298.492 $263.656
Operating activities
Research & development $58.212 $41.877 $44.018
Selling, general & administrative $286.173 $246.986 $206.014
Total operating expenses $366.089 $306.574 $266.598
Operating income -$17.51 -$8.082 -$2.942
Income from continuing operations
EBIT -$17.51 -$8.082 -$2.942
Income tax expense -$8.581 $2.174 -$2.447
Interest expense $4.164 $2.048 $0.984
Net income
Net income -$13.093 -$12.304 -$1.479
Income (for common shares) -$13.093 -$12.304 -$1.479

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $5.164 $2.684 $15.334 -$3.399
Operating activities
Depreciation $22.085 $22.77 $21.046 $20.556
Business acquisitions & disposals -$6.075
Stock-based compensation $10 $16.324 $7.691 $7.772
Total cash flows from operations $57.726 $24.566 $47.636 $27.594
Investing activities
Capital expenditures -$20.782 -$20.064 -$18.793 -$18.539
Investments $0.555 $0.529 -$1.114 $3.003
Total cash flows from investing -$28.302 -$19.535 -$19.907 -$15.536
Financing activities
Dividends paid
Sale and purchase of stock $3.207 $1.51 $3.05 $0.854
Net borrowings $298.725 -$0.651 -$0.651 -$0.675
Total cash flows from financing $239.279 -$1.153 -$20.479 -$2.522
Effect of exchange rate -$0.44 -$0.349 $0.779 -$0.435
Change in cash and equivalents $268.263 $3.529 $8.029 $9.101
(in millions USD) 2023 2022 2021
Net income -$13.093 -$12.304 -$1.479
Operating activities
Depreciation $77.048 $64.51 $48.607
Business acquisitions & disposals -$0.474 -$251.412
Stock-based compensation $33.919 $19.729 $26.16
Total cash flows from operations $74.332 $76.846 $91.969
Investing activities
Capital expenditures -$68.233 -$73.418 -$45.046
Investments $2.062 -$11.154
Total cash flows from investing -$66.171 -$85.046 -$296.458
Financing activities
Dividends paid
Sale and purchase of stock $7.325 $3.772 $3.919
Net borrowings -$2.291 $47.708 -$0.964
Total cash flows from financing -$26.482 $17.094 -$9.099
Effect of exchange rate $0.724 -$0.352 -$0.479
Change in cash and equivalents -$17.597 $8.542 -$214.067

ALNA
Allena Pharmaceuticals Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Current assets
Cash $6.589 $8.895 $29.988 $40.421
Short term investments
Net receivables
Inventory
Total current assets $16.486 $20.197 $33.006 $41.954
Long term investments
Property, plant & equipment $1.202 $1.412 $1.628 $1.788
Goodwill & intangible assets
Total noncurrent assets $1.325
Total investments
Total assets $17.811 $21.732 $34.757 $43.87
Current liabilities
Accounts payable $2.271 $3.082 $1.03 $3.027
Deferred revenue
Short long term debt $5.284 $4.893 $9.852
Total current liabilities $10.425 $10.116 $15.679 $7.673
Long term debt $9.893
Total noncurrent liabilities $3.645
Total debt $5.284
Total liabilities $14.07 $10.116 $15.889 $17.84
Stockholders' equity
Retained earnings -$266.7 -$258.265 -$246.452 -$236.089
Other stockholder equity
Total stockholder equity $3.741 $11.616 $18.868 $26.03
(in millions USD) 2021 2020 2019
Current assets
Cash $29.988 $35.042 $30.007
Short term investments
Net receivables
Inventory
Total current assets $33.006 $37.249 $33.035
Long term investments
Property, plant & equipment $1.628 $1.559 $0.95
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $34.757 $38.931 $34.108
Current liabilities
Accounts payable $1.03 $2.41 $3.048
Deferred revenue
Short long term debt $9.852 $3.992
Total current liabilities $15.679 $6.122 $10.908
Long term debt $9.853 $5.988
Total noncurrent liabilities
Total debt
Total liabilities $15.889 $16.362 $16.91
Stockholders' equity
Retained earnings -$246.452 -$197.789 -$164.944
Other stockholder equity
Total stockholder equity $18.868 $22.569 $17.198

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Revenue
Total revenue
Cost of revenue
Gross profit
Operating activities
Research & development $3.981 $7.758 $8.006 $9.024
Selling, general & administrative $2.943 $3.799 $2.115 $3.407
Total operating expenses $6.924 $11.557 $10.121 $12.431
Operating income -$6.924 -$11.557 -$10.121 -$12.431
Income from continuing operations
EBIT -$8.317 -$11.557 -$10.121 -$12.431
Income tax expense
Interest expense $0.118 -$0.249 -$0.238 -$0.25
Net income
Net income -$8.435 -$11.813 -$10.363 -$12.692
Income (for common shares) -$8.435 -$11.813 -$10.363 -$12.692
(in millions USD) 2021 2020 2019
Revenue
Total revenue
Cost of revenue
Gross profit
Operating activities
Research & development $34.972 $20.383 $37.244
Selling, general & administrative $12.677 $11.603 $9.676
Total operating expenses $47.649 $31.986 $46.92
Operating income -$47.649 -$31.986 -$46.92
Income from continuing operations
EBIT -$47.649 -$31.986 -$46.92
Income tax expense
Interest expense -$0.976 -$0.51 -$0.51
Net income
Net income -$48.663 -$32.845 -$47.339
Income (for common shares) -$48.663 -$32.845 -$47.339

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Net income -$8.435 -$11.813 -$10.363 -$12.692
Operating activities
Depreciation $0.21 $0.125 $0.122 $0.096
Business acquisitions & disposals
Stock-based compensation $0.56
Total cash flows from operations -$4.557 -$20.037 -$12.803 -$11.477
Investing activities
Capital expenditures -$0.025 -$0.185
Investments
Total cash flows from investing -$0.025 -$0.185
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$5 -$5 -$5
Total cash flows from financing $2.251 -$1.056 $2.395 $25.427
Effect of exchange rate
Change in cash and equivalents -$2.306 -$21.093 -$10.433 $13.765
(in millions USD) 2021 2020 2019
Net income -$48.663 -$32.845 -$47.339
Operating activities
Depreciation $0.363 $0.166 $0.163
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$45.678 -$28.159 -$43.632
Investing activities
Capital expenditures -$0.667 -$0.65 -$0.122
Investments
Total cash flows from investing -$0.667 -$0.632 -$0.122
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $41.291 $33.826 $12.118
Effect of exchange rate
Change in cash and equivalents -$5.054 $5.035 -$31.636

APLS
Apellis Pharmaceuticals Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $361.426 $327.026 $352.299 $453.5
Short term investments
Net receivables $304.433 $267.837 $206.442 $169.258
Inventory $175.793 $161.283 $146.362 $98.545
Total current assets $859.974 $811.428 $766.331 $796.767
Long term investments
Property, plant & equipment $20.157 $19.189 $21.09 $20.274
Goodwill & intangible assets
Total noncurrent assets $44.508 $20.502 $22.399 $21.449
Total investments
Total assets $904.482 $831.93 $788.73 $818.216
Current liabilities
Accounts payable $38.27 $26.788 $37.516 $18.192
Deferred revenue $1.903 $3.56
Short long term debt $6.214 $6.257 $6.441 $5.739
Total current liabilities $169.168 $215.291 $247.593 $185.63
Long term debt $468.296 $102.879 $104.487 $103.837
Total noncurrent liabilities $470.987 $349.963 $346.616 $400.315
Total debt $474.51 $109.136 $110.928 $109.576
Total liabilities $640.155 $565.254 $594.209 $585.945
Stockholders' equity
Retained earnings -$2,941.568 -$2,903.911 -$2,837.488 -$2,748.912
Other stockholder equity -$3.362 -$3.525 -$3.542 -$1.065
Total stockholder equity $264.327 $266.676 $194.521 $232.271
(in millions USD) 2023 2022 2021
Current assets
Cash $352.299 $553.074 $641.755
Short term investments $60.358
Net receivables $206.442 $7.727 $10.103
Inventory $146.362 $85.714 $16.286
Total current assets $766.331 $719.523 $824.047
Long term investments
Property, plant & equipment $21.09 $24.895 $26.078
Goodwill & intangible assets
Total noncurrent assets $22.399 $40.694 $57.718
Total investments $60.358
Total assets $788.73 $760.217 $881.765
Current liabilities
Accounts payable $37.516 $37.342 $16.909
Deferred revenue
Short long term debt $6.441 $5.625 $4.115
Total current liabilities $247.593 $167.61 $131.847
Long term debt $104.487 $107.088 $206.105
Total noncurrent liabilities $346.616 $422.735 $551.256
Total debt $110.928 $112.713 $210.22
Total liabilities $594.209 $590.345 $683.103
Stockholders' equity
Retained earnings -$2,837.488 -$2,308.86 -$1,656.688
Other stockholder equity -$3.542 -$0.875 -$2.09
Total stockholder equity $194.521 $169.872 $198.662

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $199.685 $172.325 $146.377 $110.399
Cost of revenue $23.1 $20.209 $19.912 $22.41
Gross profit $176.585 $152.116 $126.465 $87.989
Operating activities
Research & development $77.947 $84.701 $69.282 $79.421
Selling, general & administrative $128.081 $129.505 $141.701 $145.648
Total operating expenses $206.028 $214.206 $210.983 $225.069
Operating income -$29.443 -$62.09 -$84.518 -$137.08
Income from continuing operations
EBIT -$28.184 -$59.286 -$79.751 -$132.694
Income tax expense $0.114 $0.17 $1.423 $0.233
Interest expense $9.359 $6.967 $7.402 $7.31
Net income
Net income -$37.657 -$66.423 -$88.576 -$140.237
Income (for common shares) -$37.657 -$66.423 -$88.576 -$140.237
(in millions USD) 2023 2022 2021
Revenue
Total revenue $396.591 $75.422 $66.563
Cost of revenue $58.51 $5.636 $0.2
Gross profit $338.081 $69.786 $66.363
Operating activities
Research & development $354.387 $387.236 $345.869
Selling, general & administrative $500.815 $277.163 $176.771
Total operating expenses $855.202 $664.399 $602.64
Operating income -$517.121 -$594.613 -$536.277
Income from continuing operations
EBIT -$496.915 -$618.877 -$732.761
Income tax expense $2.132 $0.669 $0.352
Interest expense $29.581 $32.626 $13.241
Net income
Net income -$528.628 -$652.172 -$746.354
Income (for common shares) -$528.628 -$652.172 -$746.354

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income -$37.657 -$66.423 -$88.576 -$140.237
Operating activities
Depreciation $0.449 $0.444 $0.49 $0.405
Business acquisitions & disposals
Stock-based compensation $29.99 $30.349 $26.219 $21.625
Total cash flows from operations -$8.339 -$132.983 -$97.875 -$169.085
Investing activities
Capital expenditures -$0.09 -$0.293 $0.004 -$0.047
Investments
Total cash flows from investing -$0.09 -$0.293 $0.004 -$0.047
Financing activities
Dividends paid
Sale and purchase of stock $5.155 $9.477 $27.089 $5.757
Net borrowings $37.332 $98.763
Total cash flows from financing $42.487 $108.212 -$3.913 $5.746
Effect of exchange rate $0.342 -$0.209 $0.584 -$0.458
Change in cash and equivalents $34.4 -$25.273 -$101.2 -$163.844
(in millions USD) 2023 2022 2021
Net income -$528.628 -$652.172 -$746.354
Operating activities
Depreciation $1.704 $1.487 $1.492
Business acquisitions & disposals
Stock-based compensation $105.945 $91.085 $70.667
Total cash flows from operations -$594.735 -$513.745 -$563.126
Investing activities
Capital expenditures -$0.674 -$1.524 -$1.103
Investments $61.417 $248.719
Total cash flows from investing -$0.674 $59.893 $247.616
Financing activities
Dividends paid
Sale and purchase of stock $461.039 $405.841 $398.024
Net borrowings
Total cash flows from financing $394.499 $365.659 $392.236
Effect of exchange rate $0.135 -$0.488 -$2.016
Change in cash and equivalents -$200.775 -$88.681 $74.71

BAND
Bandwidth Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $62.044 $105.39 $131.987 $107.373
Short term investments $14.399 $41.839 $21.488 $31.745
Net receivables $85.576 $89.452 $78.155 $75.046
Inventory
Total current assets $181.382 $257.027 $252.775 $234.386
Long term investments
Property, plant & equipment $328.884 $330.177 $335.371 $337.886
Goodwill & intangible assets $482.186 $489.083 $502.786 $486.691
Total noncurrent assets $820.721 $828.504 $848.273 $835.696
Total investments $14.399 $41.839 $21.488 $31.745
Total assets $1,002.103 $1,085.531 $1,101.048 $1,070.082
Current liabilities
Accounts payable $31.933 $23.407 $34.208 $31.211
Deferred revenue $19.938 $20.475 $22.492 $20.272
Short long term debt $43.478 $5.089 $5.463 $4.766
Total current liabilities $156.463 $108.7 $122.771 $108.603
Long term debt $501.157 $638.739 $639.074 $640.756
Total noncurrent liabilities $538.193 $678.632 $680.887 $681.492
Total debt $544.635 $643.828 $644.537 $645.522
Total liabilities $694.656 $787.332 $803.658 $790.095
Stockholders' equity
Retained earnings -$70.068 -$74.123 -$64.89 -$53.956
Other stockholder equity -$41.015 -$38.125 -$28.794 -$49.096
Total stockholder equity $307.447 $298.199 $297.39 $279.987
(in millions USD) 2023 2022 2021
Current assets
Cash $131.987 $114.622 $332.289
Short term investments $21.488 $71.231
Net receivables $78.155 $74.465 $61.572
Inventory
Total current assets $252.775 $279.608 $412.885
Long term investments
Property, plant & equipment $335.371 $109.746 $83.665
Goodwill & intangible assets $502.786 $503.775 $555.64
Total noncurrent assets $848.273 $649.71 $652.654
Total investments $21.488 $71.231
Total assets $1,101.048 $929.318 $1,065.539
Current liabilities
Accounts payable $34.208 $26.75 $9.142
Deferred revenue $22.492 $25.536 $20.262
Short long term debt $5.463 $7.45 $5.807
Total current liabilities $122.771 $114.007 $93.498
Long term debt $639.074 $485.186 $497.398
Total noncurrent liabilities $680.887 $543.134 $559.446
Total debt $644.537 $492.636 $503.205
Total liabilities $803.658 $657.141 $652.944
Stockholders' equity
Retained earnings -$64.89 -$48.547 -$76.867
Other stockholder equity -$28.794 -$44.214 -$13.04
Total stockholder equity $297.39 $272.177 $412.595

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $173.602 $171.033 $165.386 $152.013
Cost of revenue $108.773 $105.549 $103.336 $92.514
Gross profit $64.829 $65.484 $62.05 $59.499
Operating activities
Research & development $28.132 $28.912 $28.883 $24.792
Selling, general & administrative $42.771 $46.988 $43.202 $40.854
Total operating expenses $70.903 $75.9 $72.085 $65.646
Operating income -$6.074 -$10.416 -$10.035 -$6.147
Income from continuing operations
EBIT $3.724 -$9.433 -$9.892 -$5.349
Income tax expense -$0.331 -$0.2 $0.234 -$0.219
Interest expense $0.808
Net income
Net income $4.055 -$9.233 -$10.934 -$5.13
Income (for common shares) $4.055 -$9.233 -$10.934 -$5.13
(in millions USD) 2023 2022 2021
Revenue
Total revenue $601.117 $573.152 $490.907
Cost of revenue $364.96 $334.799 $272.384
Gross profit $236.157 $238.353 $218.523
Operating activities
Research & development $104.188 $97.99 $55.173
Selling, general & administrative $167.426 $164.687 $165.587
Total operating expenses $271.614 $262.677 $220.76
Operating income -$35.457 -$24.324 -$2.237
Income from continuing operations
EBIT -$18.495 $20.354 -$2.411
Income tax expense -$2.96 -$2.264 -$3.833
Interest expense $0.808 $3.048 $28.784
Net income
Net income -$16.343 $19.57 -$27.362
Income (for common shares) -$16.343 $19.57 -$27.362

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $4.055 -$9.233 -$10.934 -$5.13
Operating activities
Depreciation $12.3 $12.414 $12.03 $10.995
Business acquisitions & disposals $0.261 $0.208 $0.183 $0.235
Stock-based compensation $11.36 $12.339 $14.667 $6.942
Total cash flows from operations $24.436 $2.465 $19.268 $23.001
Investing activities
Capital expenditures -$6.116 -$6.872 -$6.228 -$4.811
Investments $27.558 -$20.342 $10.011 -$1.124
Total cash flows from investing $21.703 -$27.006 $3.966 -$5.7
Financing activities
Dividends paid
Sale and purchase of stock $0.016 $0.103
Net borrowings -$88.832 -$0.017 -$0.047 -$0.73
Total cash flows from financing -$89.213 -$1.807 -$0.053 -$0.786
Effect of exchange rate -$0.214 -$0.394 $1.497 -$0.914
Change in cash and equivalents -$43.288 -$26.742 $24.678 $15.601
(in millions USD) 2023 2022 2021
Net income -$16.343 $19.57 -$27.362
Operating activities
Depreciation $41.717 $35.599 $42.364
Business acquisitions & disposals $1.253 $1.558
Stock-based compensation $36.992 $20.655 $14.537
Total cash flows from operations $39.001 $34.906 $40.803
Investing activities
Capital expenditures -$19.899 -$64.09 -$37.167
Investments $49.495 -$70.917 $40
Total cash flows from investing $30.849 -$133.449 $2.833
Financing activities
Dividends paid
Sale and purchase of stock $0.413 $0.163 $0.926
Net borrowings -$52.126 -$118.029 $242.244
Total cash flows from financing -$52.775 -$120.005 $207.027
Effect of exchange rate $0.61 $0.881 $0.189
Change in cash and equivalents $17.685 -$217.667 $250.852

CASA
Casa Systems Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Current assets
Cash $47.925 $64.265 $112.495 $126.312
Short term investments
Net receivables $37.36 $47.4 $47.463 $74.484
Inventory $77.206 $84.085 $83.339 $81.795
Total current assets $169.684 $204.098 $251.129 $291.779
Long term investments
Property, plant & equipment $10.101 $21.821 $23.451 $24.717
Goodwill & intangible assets $71.493 $73.01 $74.429 $75.936
Total noncurrent assets $92.832 $99.849 $105 $106.515
Total investments
Total assets $262.516 $303.947 $356.129 $398.294
Current liabilities
Accounts payable $21.891 $21.56 $15.106 $29.283
Deferred revenue $46.22 $58.197 $41.567 $36.834
Short long term debt $7.824 $8.064 $225.165 $227.201
Total current liabilities $114.432 $135.096 $312.064 $323.912
Long term debt $177.52 $174.659 $3.087 $3.416
Total noncurrent liabilities $201.509 $199.939 $24.829 $24.981
Total debt $185.344 $182.723 $228.252 $230.617
Total liabilities $315.941 $335.035 $336.893 $348.893
Stockholders' equity
Retained earnings -$286.642 -$261.024 -$209.888 -$178.23
Other stockholder equity -$3.188 -$2.937 -$1.997 -$2.305
Total stockholder equity -$53.425 -$31.088 $19.236 $49.401
(in millions USD) 2022 2021 2020
Current assets
Cash $126.312 $154.703 $157.455
Short term investments
Net receivables $74.484 $85.889 $94.267
Inventory $81.795 $84.828 $101.204
Total current assets $291.779 $355.014 $370.734
Long term investments
Property, plant & equipment $24.717 $23.508 $28.88
Goodwill & intangible assets $75.936 $81.321 $86.021
Total noncurrent assets $106.515 $113.693 $122.232
Total investments
Total assets $398.294 $468.707 $492.966
Current liabilities
Accounts payable $29.283 $28.087 $41.203
Deferred revenue $36.834 $21.485 $19.051
Short long term debt $227.201 $1.924 $15.171
Total current liabilities $323.912 $90.857 $119.161
Long term debt $3.416 $274.193 $276.085
Total noncurrent liabilities $24.981 $295.931 $297.431
Total debt $230.617 $276.117 $291.256
Total liabilities $348.893 $386.788 $416.592
Stockholders' equity
Retained earnings -$178.23 -$99.056 -$102.263
Other stockholder equity -$2.305 $0.878 $0.337
Total stockholder equity $49.401 $81.919 $76.374

Income statement

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue $62.089 $58.003 $45.297 $84.403
Cost of revenue $36.198 $34.187 $27.142 $48.427
Gross profit $25.891 $23.816 $18.155 $35.976
Operating activities
Research & development $17.121 $19.986 $20.84 $17.698
Selling, general & administrative $27.174 $20.985 $24.457 $20.162
Total operating expenses $44.295 $40.971 $45.297 $37.86
Operating income -$18.404 -$17.155 -$27.142 -$1.884
Income from continuing operations
EBIT -$14.11 -$44 -$26.302 $2.134
Income tax expense $0.796 $1.16 $0.148 -$4.456
Interest expense $10.712 $5.976 $5.208 $5.35
Net income
Net income -$25.618 -$51.136 -$31.658 $1.24
Income (for common shares) -$25.618 -$51.136 -$31.658 $1.24
(in millions USD) 2022 2021 2020
Revenue
Total revenue $286.537 $401.325 $393.246
Cost of revenue $182.871 $213.145 $192.647
Gross profit $103.666 $188.18 $200.599
Operating activities
Research & development $85.243 $84.362 $84.37
Selling, general & administrative $86.903 $85.563 $92.016
Total operating expenses $172.146 $169.925 $176.386
Operating income -$68.48 $18.255 $24.213
Income from continuing operations
EBIT -$60.97 $18.452 $26.644
Income tax expense $0.615 $0.287 -$15.052
Interest expense $17.62 $14.958 $16.895
Net income
Net income -$79.205 $3.207 $24.801
Income (for common shares) -$79.205 $3.207 $24.801

Cash flows

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$25.618 -$51.136 -$31.658 $1.24
Operating activities
Depreciation $3.301 $3.42 $3.457 $5.407
Business acquisitions & disposals
Stock-based compensation $2.572 $1.808 $4.122 $4.103
Total cash flows from operations -$14.605 $4.358 -$8.35 -$20.297
Investing activities
Capital expenditures -$0.843 -$0.305 -$0.679 -$1.094
Investments
Total cash flows from investing -$0.843 -$0.397 -$0.679 -$1.094
Financing activities
Dividends paid
Sale and purchase of stock $0.002 $0.023
Net borrowings -$0.568 -$53.279 -$1.988 -$46.628
Total cash flows from financing -$0.783 -$53.336 -$4.924 -$46.637
Effect of exchange rate -$0.009 -$0.347 $0.14 $0.851
Change in cash and equivalents -$16.24 -$49.722 -$13.813 -$67.177
(in millions USD) 2022 2021 2020
Net income -$79.205 $3.207 $24.801
Operating activities
Depreciation $15.743 $15.68 $17.97
Business acquisitions & disposals
Stock-based compensation $13.281 $14.819 $13.155
Total cash flows from operations -$8.634 $33.598 $53.642
Investing activities
Capital expenditures -$3.705 -$3.887 -$5.153
Investments
Total cash flows from investing -$4.419 -$5.326 -$5.585
Financing activities
Dividends paid -$0.001 -$0.098 -$0.683
Sale and purchase of stock $38.505 -$6.557 -$1.836
Net borrowings -$48.878 -$16.275 -$3.144
Total cash flows from financing -$12.48 -$29.395 -$6.303
Effect of exchange rate -$2.846 $0.466 $2.05
Change in cash and equivalents -$28.379 -$0.657 $43.804